EP 218: Cardiovascular genomics and preventing heart failure with Krishna Aragam of Cleveland Clinic

Value of the Information & Strength of the Argument

The podcast provides valuable insights into the current state and future directions of cardiovascular genomics. Dr. Aragam’s expertise is evident, and he articulates complex concepts clearly. The argumentation is solid, grounded in his research and clinical experience. He explains the importance of phenotypic specificity in genetic studies, using heart failure as an example, and discusses the potential of polygenic risk scores to refine risk prediction. The discussion is balanced, acknowledging both the promise and the challenges of translating genomics into clinical care.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with references to specific studies and consortia (e.g., Hermes Consortium). The sources cited in the description are relevant and credible (PMC, Nature). The title accurately reflects the content, which focuses on cardiovascular genomics and heart failure prevention. The discussion is well-structured and aligns with current literature.

The title accurately reflects the content, which focuses on cardiovascular genomics and heart failure prevention.

8/10

The discussion is led by an expert in cardiovascular genomics, with references to specific studies and consortia. The information is current and aligns with published literature, though it is primarily an expert opinion podcast rather than a peer-reviewed presentation.

• 00:00Intro to The Genetics Podcast
• 01:00Welcome to Krishna
• 01:43How a gap year in India deepened Krishna’s interest in health and population genomics
• 06:27Key advances that reshaped cardiovascular genomics from rare variants to polygenic risk
• 09:42Where cardiovascular genomics stands today across coronary disease, cardiomyopathies, and arrhythmias
• 15:13Factors that make heart failure challenging for genomics
• 18:31How monogenic variants and polygenic load shape risk in dilated cardiomyopathy
• 24:25What genetics reveals about the roots of heart failure and why precise phenotypes matter
• 27:49Using genetic risk to guide earlier treatment and prevent progression to heart failure
• 32:28Subclinical markers and imaging strategies to track progression toward heart failure
• 34:04Key research findings on an ancestry-specific genetic driver of dilated cardiomyopathy
• 43:48Genetic signals highlighting the role of inflammation in coronary artery disease
• 45:44Building a clinical genomics engine that connects discovery to cardiovascular care
• 50:02Closing remarks

• Genetic variants underlying DCM — Referenced in the description as a resource for genetic variants underlying dilated cardiomyopathy.
• Ancestry-specific CD36 study — Referenced in the description as a study on an ancestry-specific genetic driver of dilated cardiomyopathy.

• Genetic variants underlying DCM — Supports the discussion on genetic variants in dilated cardiomyopathy.
• Ancestry-specific CD36 study — Supports the discussion on ancestry-specific genetic drivers.

• drive.google.com